Few & Far Between: How Biotech Gets Built
af Chris O'Brien
Seneste episode
Episode 75: Joanne Kamens, CEO of Women in Bio
Episode 75: Joanne Kamens, CEO of Women in Bio
Om denne podcast
Welcome to Few & Far Between! Melissa Alesse, President of Biorasi, is your host for fascinating conversations - from clinical research and policymakers to biotech innovators and industry leaders.
Episoder
De nyeste 20 af 35 episoder
- Episode 75: Joanne Kamens, CEO of Women in Bio · 1 t. 2 min. · Sæson 7 Episode 75We're kicking off a new season of the Biorasi Few & Far Between podcast - and we'll be focusing on how today’s women leaders are navigating the future of biotech. Join Host…
- Episode 74: Jason Tardio, President and COO, Immunic Therapeutics · 44 min. · Sæson 6 Episode 74Today on the Biorasi Few & Far Between Podcast: Host Melissa Alesse welcomes Jason Tardio, President and COO of Immunic Therapeutics, to the podcast to explore the biotech…
- Episode 73: Isaac Stoner, CEO, MindImmune Therapeutics, Inc. · 37 min. · Sæson 6 Episode 73Today on the Biorasi Few & Far Between podcast: Host Melissa Alesse welcomes Isaac Stoner, CEO of MindImmune Therapeutics, back to the podcast for a conversation on the evolving…
- Episode 72: Joel White, Owner, Marketcap Consulting · 53 min. · Sæson 6 Episode 72Today on the Biorasi Few & Far Between podcast: What's trending in the CRO market? Find out as host Melissa Alesse welcomes Joel White, owner of Marketcap Consulting and 20+ year…
- Episode 71: Chris O'Brien, Former Biorasi CEO and Current CEO of Rancho Biosciences · 43 min. · Sæson 6 Episode 71Today on the Biorasi Few & Far Between podcast: Join new host Melissa Alesse and former host Chris O'Brien - CEO at Rancho BioSciences and Biorasi Board member - as they explore…
- Episode 69: Zak Kohane, Chair of the Department of Biomedical Informatics at Harvard Medical School · 1 t. 2 min. · Sæson 6 Episode 69Today on the Biorasi podcast, we look back on three years of AI innovation in healthcare and clinical trials - breaking new boundaries and a creating a new reality across all…
- Video Episode 68: Sinan Gölhan, CEO at GelTech Labs · 44 min. · Sæson 6 Episode 68How do today’s CEOs and founders find the balance between planning and entrepreneurship? Check out the latest episode of the Biorasi Few & Far Between podcast - How Biotech Gets…
- Video Episode 67: Aoife Brennan, President and CEO of Climb Bio · 1 t. 11 min. · Sæson 6 Episode 67Let's kick off 2026 with the first Biorasi podcast episode of the year! How do you get "Biotech Vision" to see the complete picture of your place in the industry? Find out in the…
- Episode 66: Mark Abelson, Founder of Ora Clinical · 43 min. · Sæson 5 Episode 66Are clinical trial protocols a true art form? Find out in a new episode of the Biorasi Few & Far Between podcast. Host Chris O'Brien welcomes guest Mark Ableson, founder of Ora…
- Video Episode 65 - Amit Etkin, Founder and CEO of Alto Neuroscience · 1 t. 6 min. · Sæson 5 Episode 65With biotech, is it the destination, the journey, or both? Find out in a new episode of the Biorasi Few & Far Between podcast. Host Chris O'Brien welcomes guest Amit Etkin…
- Video Episode 64 - Professor Justin Stebbing · 48 min. · Sæson 5 Episode 64Will GLP-1's one day replace our morning coffee? Find out in a special video episode of the Few & Far Between podcast! Host Chris O'Brien welcomes friend of the show, Professor…
- Video Episode 63 - Bruce Leuchter, MD, President and CEO of Neurvati Neurosciences · 1 t. 1 min. · Sæson 5 Episode 63What if the future of biotech is actually late-stage execution? Welcome to our first video episode of the Biorasi Few & Far Between podcast with your host, Chris O’Brien. Today…
- Episode 62: Ken Suzuki, Chief Marketing Officer at Nautilus Biotechnology · 44 min. · Sæson 5 Episode 62When is the right time for a biotech to bring in a Chief Marketing Officer/CMO? Find out in our latest episode of the Biorasi Few & Far Between podcast! Host Chris O'Brien…
- Episode 61: Woody Bryan, President and CEO of Revolo Biotherapeutics · 45 min. · Sæson 5 Episode 61Why is a feather-light touch important in fighting infections? Find out in our latest episode of the Biorasi Few & Far Between podcast! Host Chris O'Brien welcomes Woody Bryan…
- Episode 60: Part Two: Yochi Slonim, Co-Founder and CEO at Anima Biotech · 42 min. · Sæson 5 Episode 60Can AI see and talk to human cells? Find out in today's episode of the Biorasi Few & Far Between podcast. Host Chris O'Brien welcomes Yochi Slonim, Co-Founder and CEO at Anima…
- Episode 59, Part One: Yochi Slonim, Co-Founder and CEO at Anima Biotech · 44 min. · Sæson 5 Episode 59What do software bugs and human cells have in common? Find out in today's episode of the Biorasi Few & Far Between podcast. Host Chris O'Brien welcomes Yochi Slonim, Co-Founder…
- Episode 58: Jerry McLaughlin, CEO and Board Member at Life Biosciences · 45 min. · Sæson 5 Episode 58How does a biopharma background prepare you for the biotech playground? Find out in our latest episode of the Biorasi Few & Far Between podcast! Host Chris O'Brien welcomes Jerry…
- Episode 57: Jim Brown, DVM, President and CEO of DURECT Corporation · 45 min. · Sæson 5 Episode 57Is the epigenome the "software" of the cell nucleus? Find out in our latest episode of the Biorasi Few & Far Between podcast! Host Chris O'Brien welcomes Jim Brown, President and…
- Episode 56, Part Two: Michael Tolentino, MD, Co-Founder and Head Scientific Consultant, Aviceda Therapeutics · 39 min. · Sæson 5 Episode 56How do experienced troubleshooters solve a difficult problem? By asking the right questions first! Welcome back to part two of our conversation with Michael Tolentino, MD…
- Episode 55: Julio G. Martinez-Clark, CEO and Co-Founder at bioaccess® · 39 min. · Sæson 5 Episode 55How much do you know about clinical trials in Latin America? Take a deep dive with us as we explore the benefits and risks of running studies in this region. In our latest…
